Home / Diabetes In Control (page 295)

Diabetes In Control

Diabetes Expenses Have Decreased but Still High

Out-of-pocket expenses for diabetes treatment have gone down for many U.S. patients over the past decade, according to a new study. But nearly a quarter of people with diabetes still face high expenses. In particular, (out-of-pocket) expenses declined in the people with public insurance and in people with low income …

Read More »

Obesity Blamed for Rise in Diabetes

 An ‘alarming’ rise in obesity has contributed to a dramatic increase in the prevalence of diabetes in the U.S, according to a new study. Researchers examined the prevalence of diabetes, prediabetes, and glycemic control in 43,439 adults in the NHANES study from 1988 to 1994 and 1999 to 2010. The …

Read More »

In Two Decades, Diabetes Doubled

The authors of a new study found that the rise in diabetes from 5.5% to 9.3% of the U.S. population over the last 20 years paralleled the growing rate of obesity in America. Better screening tools such as the HbA1c diagnostic test have also helped physicians identify more diabetes cases, …

Read More »

FDA Approves Albiglutide, a Once-Weekly GLP-1 Injectable Diabetes Drug

The Food and Drug Administration (FDA) has approved albiglutide (Tanzeum, GlaxoSmithKline), a once-weekly injectable glucagonlike peptide 1 (GLP-1) receptor agonist to treat type 2 diabetes…. “Tanzeum is a new treatment option for the millions of Americans living with type 2 diabetes,” Curtis Rosebraugh, MD, MPH, director of the Office of …

Read More »